Haemonetics HAE
$
Relative Strength Index (RSI)
- The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. It is typically used to identify overbought or oversold conditions in financial markets.
- The RSI is calculated using the following formula:
RSI = 100 - (100 / (1 + RS))
Where RS is the ratio of the average gains to the average losses over a specified period.
- The default time period used is 14 days.
- RSI values range between 0 and 100.
RSI values above 70 are considered overbought (indicating a potentially opportune time to sell)
RSI values below 30 are considered oversold (indicating a potentially opportune time to buy)
RSI is not a perfect indicator and should be used in conjunction with other technical analysis tools, this is for informational purposes only and is not a substitute for professional financial advice.
Key Insights
Haemonetics (HAE) Core Market Data and Business Metrics
Latest Closing Price
$64.04Price-Earnings Ratio
26.57Total Outstanding Shares
50.24 Million SharesDividend
No dividendSIC Description
Surgical & Medical Instruments & ApparatusPrimary Exchange
New York Stock ExchangeHeadquarters
125 Summer Street, Boston, MA, 02110
Historical Stock Splits
If you bought 1 share of HAE before December 3, 2012, you'd have 2 shares today.
| Execution Date | Split Amount |
|---|---|
| December 3, 2012 | 2-for-1 |
Short Interest
Track Short Interest Levels to Gauge Bearish Market Sentiment and Short Squeeze Potential
| Avg Daily Volume | Days to Cover | Settlement Date | Short Interest |
|---|---|---|---|
| 918,847 Shares | 6.56 | 3/14/2025 | 6,028,768 Shares |
| 982,992 Shares | 6.58 | 2/28/2025 | 6,468,224 Shares |
| 1,781,301 Shares | 3.84 | 2/14/2025 | 6,832,676 Shares |
| 882,077 Shares | 5.94 | 1/31/2025 | 5,242,500 Shares |
| 418,431 Shares | 11.85 | 1/15/2025 | 4,959,780 Shares |
| 497,050 Shares | 10.52 | 12/31/2024 | 5,229,686 Shares |
Cash Flow Statement
September 29, 2023 to September 28, 2024
| Metric | Value |
|---|---|
| Exchange Gains/Losses | $3.08 Million |
| Net Cash Flow From Financing Activities, Continuing | $304.81 Million |
| Net Cash Flow From Operating Activities | $84.94 Million |
| Net Cash Flow From Financing Activities | $304.81 Million |
| Net Cash Flow From Investing Activities, Continuing | $-444.56 Million |
| Net Cash Flow, Continuing | $-54.80 Million |
Income Statement
September 29, 2023 to September 28, 2024
| Metric | Value |
|---|---|
| Net Income/Loss | $123.81 Million |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0 |
| Costs And Expenses | $1.20 Billion |
| Depreciation and Amortization | $109.52 Million |
| Benefits Costs and Expenses | $1.20 Billion |
| Diluted Average Shares | $154.25 Million |
Comprehensive Income
September 29, 2023 to September 28, 2024
| Metric | Value |
|---|---|
| Comprehensive Income/Loss Attributable To Parent | $121.95 Million |
| Comprehensive Income/Loss | $121.95 Million |
| Other Comprehensive Income/Loss | $-1.86 Million |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0 |
Balance Sheet
September 29, 2023 to September 28, 2024
| Metric | Value |
|---|---|
| Intangible Assets | $487.84 Million |
| Noncurrent Assets | $1.57 Billion |
| Current Liabilities | $273.95 Million |
| Other Current Liabilities | $155.40 Million |
| Other Current Assets | $573.80 Million |
| Noncurrent Liabilities | $1.37 Billion |
Historical Dividends
| Announcement Date | Payment Date | Record Date | Amount | Frequency |
|---|---|---|---|---|
| No historical dividends | ||||